Type 2 Diabetes Mellitus Clinical Trial
Official title:
Nutrition Education Intervention for Adults With Type 2 Diabetes Receiving Outpatient Services at a Teaching Tertiary Hospital in Tshwane District
Aim: To implement a nutrition education programme (intervention) for adults with type 2
diabetes mellitus (T2DM) adapted from a primary health care setting to a tertiary hospital
setting in South Africa and to evaluate the programme's effectiveness on dietary behaviours,
clinical status and selected potential behaviour mediators.
Participants and setting: T2DM adults (40-70 years) and at least one year of living with
diabetes and poorly controlled diabetes (HbA1c ≥ 8%). The study setting is the outpatient
clinic of a tertiary teaching hospital in Tshwane District (Pretoria), South Africa.
Intervention: The intervention will employ a randomised control design with two parallel
groups (intervention & control). A total sample of 140 T2DM patients (70 per group) will be
needed to detect a 0.5 % change in HbA1c (SD of 1.0 and a power of 80%) at six month and
allowing a 10% attrition rate. The intervention is one-year long with the following
components: 7-monthly group education sessions; 2 bi-monthly group follow-up sessions at the
hospital till one year; participants' workbook for goal setting activities and education
materials (pamphlet and wall/fridge poster) for the intervention group. The control group
will receive the same education materials with no other education encounters. Both groups
will continue with usual care at the diabetes outpatient clinic of the hospital. The
education will be offered face to face, will utilize teaching aids including coloured posters
and will incorporate interactive group activities and demonstrations. The main facilitator is
a qualified dietitian.
Outcomes: Outcomes will be assessed at 6-and 12 months for both groups with the six month
being the primary outcome. Outcomes will include clinical [HbA1c (primary outcome), BMI,
blood pressure and full lipid profile); dietary behaviours (energy intake, starchy food
servings, vegetable and fruits intake, macronutrient intake and their distribution to energy,
fibre, meal pattern) and selected potential mediators of behavior (diabetes knowledge and
diabetes management self- efficacy).
It is hypothesized that the intervention will lower the HbA1c levels by at least 0.5% at six
months and the levels will be significantly lower in the intervention group compared with the
control group, and the significantly lower levels will be sustained at 12 months in the
intervention group.
Aim of the study: To implement a nutrition education program (intervention) for adults with
type 2 diabetes mellitus (T2DM) adapted from a primary health care setting to a tertiary
hospital setting in South Africa and to evaluate the program's effectiveness on dietary
behaviors, clinical status and selected potential behavior mediators.
General objectives
• The implementation of the adapted nutrition education program (NEP) at the diabetes
outpatient clinic of a tertiary teaching hospital
• The evaluation of the program's effectiveness at six and 12 months on the following
outcomes: (i) clinical status: Hemoglobin A1c (HbA1c) (primary outcome), BMI, blood pressure
and lipid profile (ii) dietary behaviors (energy intake, starchy food servings, vegetable and
fruits intake, macronutrient intake and their distribution to energy as a measure of meal
balance, fiber and legume intake) (iii) potential behavior mediators (diabetes knowledge,
diabetes management self-efficacy).
Primary outcome objective
• To determine the differences between the intervention and control groups at six months for
HbA1c, (primary outcome).
Secondary outcome objectives
- To determine the differences between the intervention and control groups at 12 months
for HbA1c
- To determine the differences between the intervention and control groups at six months
and 12 months for the secondary outcomes: dietary behaviors, BMI, lipid profile, blood
pressure, diabetes knowledge and self-efficacy for diabetes management
- To determine the differences between the intervention and control groups in the
proportion of participants who achieve HbA1c levels of less than 7%.
Research hypotheses (i) The intervention will lower the HbA1c levels by at least 0.5% at six
months and the levels will be significantly lower in the intervention group compared with the
control group, and the significantly lower levels will be sustained at 12 months in the
intervention group.
(ii) The intervention group will have significantly better outcomes in the secondary outcomes
(blood lipid levels, BMI, blood pressure, dietary behaviors, diabetes knowledge and
self-efficacy) at six months and would sustain significantly better outcomes at 12 months
compared with the control group.
(iii) The intervention group compared with the control group would have significantly more
participants achieving the HbA1c targets (<7%) at six months and at 12 months.
Study design The intervention will employ a randomized controlled clinical trial design using
two parallel groups. One group (intervention) will receive the intervention (diabetes
nutrition education) including education materials while the other group (control) will only
receive the education materials. Both groups will continue with usual medical care at the
diabetes outpatient clinic.
Setting and participants: The study setting is the outpatient clinic of a tertiary teaching
hospital in Pretoria, South Africa. Participants are male and female T2DM adults (40-70
years) and at least one year of living with diabetes and poorly controlled diabetes (HbA1c ≥
8%). Participants with no major complications, who are not pregnant or on full time
employment and can understand English will be included. A total sample of 140 T2DM patients
(70 per group) will be needed to detect a 0.5 % change in HbA1c (SD of 1.0 and a power of
80%) at six month and allowing a 10% attrition rate. A convenience sample of consequent
patients will be used. Participants will be recruited face to face during their clinic
attendance.
Randomization Participants will be randomised into either the intervention or control group
using block randomisation in blocks of varying sizes using a computer generated random
schedule. The participants will be stratified based on sex and age. Allocation concealment
using sealed sequentially numbered opaque envelopes with the randomisation code will be done
(Sex-age stratum will have its own set of the sequentially numbered opaque envelope).
Intervention: The intervention aims to improve glycaemic control and other clinical outcomes
(BMI, lipid profile, blood pressure) through improved dietary behaviours and behaviour
mediating factors. The intervention is one-year long.
The intervention group will receive the following components:
- Face to face 7-monthly group education sessions, 2 bi-monthly group follow-up sessions
at the hospital up to one year and one individual counseling and goal setting activity
- Participate in individual goal setting activities at home using a workbook and receive
education materials (pamphlet and wall/fridge poster) for use at home.
The education will be offered face to face, will utilize teaching aids including colorful
posters and will incorporate interactive group activities and demonstrations. Participants
will be encouraged to bring a family member or a friend. The main facilitator is a qualified
dietitian.
The control group will receive the same education materials with no other education
encounters. Both groups will continue with usual care at the diabetes outpatient clinic of
the hospital.
Outcomes measurement: Outcomes will be assessed at 6-and 12 months for both groups with the
six month being the primary outcome.
- Clinical outcomes: HbA1c (primary outcome), BMI, blood pressure and full lipid profile)
will be measured using standard procedures.
- Dietary behaviors (energy intake, starchy food servings, vegetable and fruits intake,
legume intake, macronutrient intake and their distribution to energy as a measure of
meal balance and fibre). Three non-consecutive 24hour recalls (including one weekend
day) will assess dietary intake. Standardized household measures will be used to help
with portion estimation.
- Potential mediators of behavior (diabetes knowledge and diabetes self-management
efficacy). Questionnaires considered as suitable measures for the outcomes and
appropriate for use with the target population (through pilot testing) will be used. The
questionnaires have been used in diverse settings and geographical locations.
Process evaluation: Quantitative and qualitative measures will be used to confirm fidelity,
reach and participants experience with the programme.
Data analysis:
An analysis of co-variance (ANCOVA) will compare the intervention and control groups on the
measured outcomes post-intervention, using the baseline values age and gender as covariates.
An intention to treat analysis will be performed on all outcomes using the last observed
response (carry forward). The level of significance for all tests will be at α < 0.05 for a
two-tailed test.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02226003 -
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
|
Phase 3 |